These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2774373)

  • 1. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
    Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
    Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
    Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
    Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa.
    Conjeevaram HS; Hoofnagle JH; Austin HA; Park Y; Fried MW; Di Bisceglie AM
    Gastroenterology; 1995 Aug; 109(2):540-6. PubMed ID: 7615204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon for hepatitis B: US experience.
    Perrillo RP
    Gut; 1993; 34(2 Suppl):S95-6. PubMed ID: 8314498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranous nephropathy related to hepatitis B virus in adults.
    Lai KN; Li PK; Lui SF; Au TC; Tam JS; Tong KL; Lai FM
    N Engl J Med; 1991 May; 324(21):1457-63. PubMed ID: 2023605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.
    Pastore G; Santantonio T; Milella M; Monno L; Mariano N; Moschetta R; Pollice L
    J Hepatol; 1992 Mar; 14(2-3):221-5. PubMed ID: 1500686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
    Hoofnagle JH; Peters M; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Hallahan C; Park Y; Meschievitz C; Jones EA
    Gastroenterology; 1988 Nov; 95(5):1318-25. PubMed ID: 3049216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
    Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
    Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatitis B virus-associated nephropathy in black children.
    Bhimma R; Coovadia HM; Kramvis A; Adhikari M; Kew MC
    Pediatr Nephrol; 2002 Jun; 17(6):393-9. PubMed ID: 12107801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.